Victoria Indenbaum

Tel Aviv University — Israel

Medicine · Health Sciences

25h-index3.8kcitations83works3.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(59), COVID-19 Clinical Research Studies(25), SARS-CoV-2 detection and testing(17), Vaccine Coverage and Hesitancy(13), Animal Virus Infections Studies(10)

Publications83 total

Immune Responses to SARS-CoV-2 Variants WT and XBB.1.9: Assessing Vulnerabilities and Preparedness
Vaccines·2025Open Access
Molecular Evidence of Dengue Virus Serotype 2 in Travelers Returning to Israel from the Sinai Peninsula
Emerging infectious diseases·2025Open Access
Crimean-Congo Hemorrhagic Fever Virus in Cattle and Ticks, Israel
Emerging infectious diseases·2025Open Access
Diagnostic insights from the 2024 West Nile Virus outbreak in Israel: Emphasizing the utility of molecular testing over serology
Journal of Clinical Virology·2025
Immune Responses to SARS-CoV-2 Variants WT and XBB.1.9: Assessing Vulnerabilities and Preparedness
2025Open Access
Sensitivity and Cross-Reactivity Analysis of Serotype-Specific Anti-NS1 Serological Assays for Dengue Virus Using Optical Modulation Biosensing
Biosensors·2025· 2 citedOpen Access
Travel-related congenital Zika infection associated with Asian lineage virus acquired in Thailand
Journal of Travel Medicine·2025· 1 cited
Measles Sequencing: Lessons Learned from a Large-Scale Outbreak
Viruses·2025· 1 citedOpen Access
Correction: West Nile Virus Outbreak in Israel 2024 Compared with Previous Seasons: A Retrospective Study
Infectious Diseases and Therapy·2025· 1 citedOpen Access
West Nile Virus Outbreak in Israel 2024 Compared with Previous Seasons: A Retrospective Study
Infectious Diseases and Therapy·2025· 6 citedOpen Access
Circulating lncRNAs as biomarkers for severe dengue using a machine learning approach
Journal of Infection·2025· 3 citedOpen Access
Persistence of Long COVID Symptoms Two Years After SARS-CoV-2 Infection: A Prospective Longitudinal Cohort Study
Viruses·2024· 12 citedOpen Access
SARS-CoV-2 Omicron XBB.1 variant outbreak in a defined cohort: an epidemiological investigation incorporating longitudinal assessment of humoral response
International Journal of Infectious Diseases·2024Open Access
Risk factors and correlates of protection against XBB SARS-CoV-2 infection among health care workers
Vaccine·2024· 6 cited
Early rise of West Nile fever in Israel, June 2024
Eurosurveillance·2024· 13 citedOpen Access
Humoral response superiority of the monovalent XBB.1.5 over the bivalent BA.1 and BA.5 mRNA COVID-19 vaccines
Vaccine·2024· 9 cited
SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022 and 2023
Emerging infectious diseases·2024· 6 citedOpen Access
Does the SARS-CoV-2 mRNA vaccine and its serum IgG levels affect fertility treatments and obstetric outcomes? An observational cohort study
Clinical and Experimental Medicine·2024· 3 citedOpen Access
Rapid molecular epidemiology investigations into two recent measles outbreaks in Israel detected from October 2023 to January 2024
Eurosurveillance·2024· 2 citedOpen Access
Measles outbreak associated with a preschool setting among partially vaccinated children in the Tel Aviv District, Israel, October 2023
Vaccine·2024· 2 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Yaniv Lustig(41), Ella Mendelson(25), Gili Regev‐Yochay(24), Michal Mandelboim(19), Yitshak Kreiss(19), Ram Doolman(18), Keren Asraf(18), Sharon Amit(16), Galia Rahav(13), Carmit Cohen(12), Mayan Gilboa(11), Yael Weiss-Ottolenghi(11), Neta S. Zuckerman(10), Laurence S. Freedman(10), Itzchak Levy(10), Noam Barda(10), Carmit Rubin(9), Liraz Olmer(9), Orna Mor(9), Merav Weil(9)